Class IIReported 2026-03-11

Midodrine Hydrochloride Tablets, USP, 5 mg, 50 Tablets (5 x 10 blister packs), Rx only, Packaged and Distributed by: Major Pharmaceuticals, Indianapolis, IN 46268 USA, NDC 0904-6818-06.

Recalled by The Harvard Drug Group LLC

Reason for Recall

Defective container; inadequately sealed blister packaging.

Recall Number

D-0383-2026

Classification

Class II

Status

Ongoing

Category

drug

Initiated

2026-02-17

Reported

2026-03-11

Distribution

Nationwide US.

Code Info

Lot # N02640, Exp Date: 08/2027

Source: openFDA enforcement report. WhichRecall is not affiliated with the FDA. See our disclaimer.